HRT

ANALYST NOTE: HRT (HireRight Holdings Corporation) Date: 2026-06-13 Current Price: $14.36

1. Structural Readiness

State: Avoid Conservative Entry: Not actionable (awaiting confirmed breakout) Aggressive/Pre-Breakout Entry: Not recommended (sub-threshold volatility) Breakout Level: Not yet established. Extension: N/A (Price is not in an extended breakout phase). ATR Context: Current ATR is 0.2% (sub-threshold). This indicates extremely low volatility, which historically correlates with weak momentum and a lack of immediate directional conviction.

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None named at this date. Assessment: This is a TACTICAL, setup-led name. There is no named macro or secular thesis driving the current setup as of 2026-06-13. The investment case must be judged strictly on the quality of the technical setup (which is currently forming but unconfirmed) and the underlying business fundamentals. Do not invent a thesis; the current data does not support a high-conviction secular narrative (e.g., "AI-driven screening boom" or "Global compliance mandate") that would override the technical weakness. The conviction stack relies entirely on the potential for a "Deep Value Recovery" to materialize if the technical structure resolves to the upside.

3. The Business

Company Overview: HireRight Holdings Corporation operates as a technology-driven provider for global workforce risk management and compliance. The company delivers a comprehensive suite of services including background checks, identity verification, continuous monitoring, and drug and health screenings. These services are delivered via an advanced software and data platform that integrates with customers' Human Capital Management (HCM) systems to streamline talent acquisition and onboarding workflows.

Business Model & Evidence (as of 2026-06-13):

• Revenue Drivers: The company relies on a mix of new business acquisition and retention of a large base of existing customers.
• Strategic Partnerships: As of the last available earnings data (2023-11-07), the company secured significant strategic wins, including being selected by UKG (Ultimate Kronos Group) as their sole go-to-market partner for "UKG Screen by HireRight" and becoming the exclusive background screening provider in Oracle's ISV Accelerator Program.
• Financial Performance (Historical Context):
• New Business: In the period ending 2023-11-07, new business revenue drove over $36 million in growth, with a pipeline described as "as strong as it has ever been."
• Enterprise Wins: The quarter saw the addition of 5 new enterprise customers with a combined estimated annual contract value (ACV) of $11 million.
• Base Growth Concern: Despite new wins, the company reported that base growth from its top ~1,800 customers (representing ~75% of total revenue) was negative 16% year-over-year during that same period.
• Restructuring: Management had set a target of $50 million in total run-rate savings by the end of 2024 from restructuring activities.
• Outlook (Historical): Management previously provided an outlook for revenue of $720M–$735M and adjusted EBITDA of $172M–$177M (as of late 2023).
• Current Financial Spine (2026-06-12): The financial spine data indicates a Forward consensus EPS (FY1) of 0. This is a critical data point suggesting that, as of mid-2026, the market expects the company to be at or near break-even on an earnings basis, or that the consensus has collapsed to zero due to uncertainty or restructuring impacts.

4. Archetype and Conviction

Archetype: Deep Value Recovery Fit Analysis: The name fits the Deep Value Recovery archetype. The company is trading at a low price ($14.36) with a consensus EPS of zero, suggesting the market has priced in significant distress or a turnaround scenario. The "Deep Value" aspect is supported by the historical evidence of strong new business growth ($36M YTD) and strategic partnerships (UKG, Oracle), which contrast with the negative base growth (-16%) and the zero EPS consensus.

Conviction Stack:

• Thesis Strength: Low. No named secular thesis; purely tactical.
• Evidence Quality: Mixed. Strong evidence of new business acquisition and strategic partnerships (E1, E2, E5, E6) is offset by the negative base growth (E8) and the zero EPS consensus (E12).
• Structural Quality: Weak. The ATR is 0.2% (sub-threshold), indicating a lack of volatility and momentum. The setup is "Forming" but not "Confirmed."
• Setup Readiness: Low. The coil is forming, but the breakout has not fired. The sub-threshold ATR suggests the market is not yet engaging with the stock.
• Rerating Potential: Unclear. While the "Deep Value" label implies potential for rerating if the turnaround succeeds, the zero EPS consensus and negative base growth history create a high barrier to immediate rerating.

ATR Context: The current ATR of 0.2% is sub-threshold (canonical bucket: <2.5%). This is a weak signal for sizing. Historically, the "sweet spot" for momentum setups is 4–6% ATR. A 0.2% ATR suggests the stock is dormant. A breakout from such a low-volatility state could be explosive, but the probability of a false breakout or continued stagnation is high without a catalyst.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

• Fundamental: Confirmation that the "Deep Value" thesis is a value trap, evidenced by continued negative base growth or a failure to achieve the previously targeted $50M in run-rate savings.
• Financial: A revision of the FY1 consensus EPS from 0 to negative, indicating the company is not just at break-even but losing money.

What Would Strengthen the Case:

• Technical: A high-volume breakout above the coil resistance with an ATR expansion into the 4–6% range.
• Fundamental: Evidence that the new business revenue ($36M+ from 2023) has successfully offset the negative base growth, leading to positive EPS growth in the 2026 fiscal year.
• Strategic: Expansion of the UKG or Oracle partnerships into new revenue streams.

Gaps in Evidence Base:

• 2024-2026 Performance Data: The most recent earnings transcript is from 2023-11-07. There is a significant gap in specific financial performance data for the years 2024, 2025, and the first half of 2026. We do not know if the $50M savings target was met, nor do we know the actual trajectory of the "strong pipeline" mentioned in 2023.
• Current Valuation Drivers: The "Forward consensus EPS of 0" is a snapshot, but we lack the specific revenue growth rates or margin expansion data for 2026 to confirm if the "Deep Value" is justified or if the company is in a permanent state of stagnation.
• Sector Context: The sector and industry classification are missing from the current data, making it difficult to benchmark the stock against peers.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: low Key evidence: 1) Technical setup is "Forming" with sub-threshold ATR (0.2%) indicating lack of momentum; 2) Forward consensus EPS is 0, suggesting market expects no earnings growth; 3) Historical data shows negative base growth (-16%) despite new business wins. Sizing hint: Position size should be minimal or zero until ATR expands and breakout confirms; current volatility is too low to justify risk. Expected path: Management expectations for savings and new business must translate to positive EPS; if the technical structure resolves to a breakout with volume, the setup becomes active. Expected horizon: 3-6 months for technical resolution or fundamental confirmation.